Raffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk

Dow Jones

Dec 05, 2024

0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com)

(END) Dow Jones Newswires

December 05, 2024 01:34 ET (06:34 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2489100122"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2489100122\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2489100122?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-05 14:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489100122","market":"fut","top_or_hot":-1,"title":"Raffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 05, 2024 01:34 ET (06:34 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Raffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRaffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-12-05 14:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 05, 2024 01:34 ET (06:34 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSL.SI","symbol_name":"莱佛士医疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2489100122","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489100122","pubTimestamp":1733380440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BSL.SI":"莱佛士医疗"},"translate_title":"莱佛士医疗面临保险业务亏损的盈利打击——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSL.SI":1},"content_text":"0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 05, 2024 01:34 ET (06:34 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}